Aleva Neurotherapeutics SA

The electrode leads used for deep brain stimulation to treat such conditions as Parkinson’s disease, depression and essential tremors have become a lot smarter, thanks to technology developed by Switzerland’s Aleva Neurotherapeutics SA. The company’s microDBS platform is an evolution of micro-electro-mechanical systems that allows for precise stimulation of targeted brain tissue, leaving the adjacent region unaffected.